Website Update in Progress

Our website is currently being updated. Investor Relations information and the full Press Releases archive remain available below.

Under construction Live soon

Investor Relations

Press Releases

Oramed and Lifeward Announce Strategic Transaction

January 13, 2026

Press Releases

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

January 7, 2026

Press Releases

Oramed Reports Fiscal Third Quarter 2025 Financial Results

November 17, 2025

Press Releases

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

November 17, 2025

Press Releases

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives

October 23, 2025

Press Releases

Copyright © 2025 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy